Precision Optics (NASDAQ:POCI) vs. Heyu Biological Technology (OTCMKTS:HYBT) Financial Contrast

Precision Optics (NASDAQ:POCIGet Free Report) and Heyu Biological Technology (OTCMKTS:HYBTGet Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Volatility and Risk

Precision Optics has a beta of 0.13, indicating that its share price is 87% less volatile than the S&P 500. Comparatively, Heyu Biological Technology has a beta of -17.74, indicating that its share price is 1,874% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for Precision Optics and Heyu Biological Technology, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics 0 0 0 0 N/A
Heyu Biological Technology 0 0 0 0 N/A

Valuation and Earnings

This table compares Precision Optics and Heyu Biological Technology’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Precision Optics $19.41 million 1.79 -$140,000.00 ($0.28) -20.39
Heyu Biological Technology $80,000.00 322.65 -$270,000.00 N/A N/A

Precision Optics has higher revenue and earnings than Heyu Biological Technology.

Profitability

This table compares Precision Optics and Heyu Biological Technology’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Precision Optics -8.43% -19.07% -11.81%
Heyu Biological Technology -453.55% -6.43% -4.43%

Institutional and Insider Ownership

13.7% of Precision Optics shares are owned by institutional investors. 16.3% of Precision Optics shares are owned by insiders. Comparatively, 89.2% of Heyu Biological Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Precision Optics beats Heyu Biological Technology on 5 of the 9 factors compared between the two stocks.

About Precision Optics

(Get Free Report)

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

About Heyu Biological Technology

(Get Free Report)

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.